›› 2014, Vol. 9 ›› Issue (2): 60-63.doi:
LI Yan-ru, TIAN Li-juan
LI Yan-ru, TIAN Li-juan
摘要: Objective To study the current status of biosimilars, and to explore strategies for the healthy development of biosimilars in China.
Methods Literature review was conducted to summarize the status of biosimilars both at home and abroad. Results and Conclusion
The development of biosimilars in China is not yet mature compared with the advanced countries. Support from both companies and
the state is needed to promote the development of biosimilars in China.